Association between serum non-HDL-C and cardiovascular disease mortality risk
10.3760/cma.j.cn112150-20241123-00939
- VernacularTitle:血清非高密度脂蛋白胆固醇与心血管病死亡风险的关联研究
- Author:
Baocheng DONG
1
;
Longfei MAO
;
Haitao WEI
;
Shuxia ZHU
;
Xiangping TANG
;
Liuting XU
;
Lixiang CHAI
;
Yelu RUAN
;
Shunqin HUANG
;
Jianbing WANG
Author Information
1. 浙江大学公共卫生学院，杭州 310058
- Publication Type:Journal Article
- Keywords:
Non-high-density lipoprotein cholesterol;
Cardiovascular disease;
Mortality;
Cohort studies
- From:
Chinese Journal of Preventive Medicine
2025;59(10):1763-1769
- CountryChina
- Language:Chinese
-
Abstract:
To analyze the relationship between serum non-HDL-C levels and cardiovascular disease (CVD) mortality in community populations. A retrospective cohort study was conducted using the Yuecheng District Health Information Platform in Shaoxing City, Zhejiang Province. The study cohort included individuals aged 40 years or older with no prior history of CVD who underwent physical examinations at Yuecheng District healthcare institutions between January and December 2019. A total of 39 038 participants were included, including 19 085 males (48.9%) and 19 953 females (51.1%), with a mean age of (73.64±9.10) years. The mean follow-up duration was 52.3 months. During follow-up, 1 227 CVD death events occurred. The results indicated a significant overall association between non-HDL-C levels and the risk of CVD mortality, including coronary heart disease (CHD) and stroke. Cox models indicated that, using the ideal level of non-HDL-C as the reference, the hazard ratios (HRs) for risk of CVD death in the suitable level, borderline elevated level and elevated level groups were 1.24 (95% CI: 1.08-1.42), 1.57 (95% CI: 1.34-1.85) and 2.31 (95% CI: 1.87-2.86), respectively. The corresponding HRs for CHD death were 1.39 (95% CI: 1.10-1.76), 1.69 (95% CI: 1.28-2.12) and 2.53 (95% CI: 1.76-3.64), respectively. Subgroup analysis revealed significant interaction effects between non-HDL-C and sex, smoking, alcohol consumption, and diabetes (all P interaction<0.05). Sensitivity analyses confirmed that results were consistent with the primary findings regarding the association between non-HDL-C and CVD mortality risk. In conclusion, increasing non-HDL-C levels are associated with higher risks of death from cardiovascular diseases, including stroke and CHD. The risk of CVD death associated with elevated non-HDL-C is greater among males, individuals with a history of diabetes, smokers or drinkers. In the future, attention should be paid to the monitoring of non-HDL-C in community health management, and the intensive and personalized management of blood lipids in high-risk population should be strengthened.
